Hypertension and Atrial Fibrillation treated by Rivaroxaban for the Morning and Night with synergy with calcium antagonists

Trial Profile

Hypertension and Atrial Fibrillation treated by Rivaroxaban for the Morning and Night with synergy with calcium antagonists

Recruiting
Phase of Trial: Phase III

Latest Information Update: 16 Jun 2016

At a glance

  • Drugs Rivaroxaban (Primary) ; Nifedipine
  • Indications Atrial fibrillation
  • Focus Therapeutic Use
  • Acronyms HARMONY
  • Most Recent Events

    • 03 Apr 2015 Status changed from not yet recruiting to recruiting, according to University Hospital Medical Information Network - Japan record.
    • 03 Dec 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top